|
SFDA issues the No.84 announcement of drug administrative protection
|
|
The State Food and Drug Administration (SFDA) issued the No.84 Drug Administrative Protection Announcement on February 28, 2006, declaring Eli Lilly and Company 's Cymbalta (duloxetine hydrochloride) Enteric Coated Capsule proceed to substantive examination.
| |
|
|
